Are you Dr. Ishizawar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 76 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2800 Blue Ridge Rd
Ste 204
Raleigh, NC 27607Phone+1 919-784-3324
Summary
- Dr. David Ishizawar, MD is a cardiologist in Raleigh, North Carolina. He is currently licensed to practice medicine in North Carolina, Wisconsin, and Pennsylvania. He is affiliated with Froedtert and the Medical College of Wisconsin Froedtert Hospital and is an Assistant Professor at University of Pittsburgh School of Medicine.
Education & Training
- UPMC Medical EducationFellowship, Cardiovascular Disease, 2004 - 2007
- UPMC Medical EducationResidency, Internal Medicine, 2001 - 2004
- University of Pittsburgh School of MedicineClass of 2001
Certifications & Licensure
- NC State Medical License 2023 - 2025
- WI State Medical License 2016 - 2023
- PA State Medical License 2001 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Publications & Presentations
PubMed
- 1 citationsSuccessful treatment of pulmonary hypertension following hematopoietic stem cell transplant with a single oral tadalafil: a case report:Toshikazu D. Tanaka, David Ishizawar, Takeshi Saito, Akira Yoshii, Michihiro Yoshimura
Pulmonary Circulation. 2021-06-28 - 139 citationsGenomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertensionRevathi Rajkumar, Kazuhisa Konishi, Thomas J. Richards, David Ishizawar, Andrew C. Wiechert
American Journal of Physiology. Heart and Circulatory Physiology. 2010-04-01 - 86 citationsHigh Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4Eileen M. Bauer, Richard A. Shapiro, Han Zheng, Ferhaan Ahmad, David Ishizawar
Molecular Medicine. 2012-12-20
Professional Memberships
- Member